BUPA Finance PLC Bupa announces price of Fixed & Subordinated Notes (4269Q)
18 Junho 2020 - 12:51PM
UK Regulatory
TIDMBUPF
RNS Number : 4269Q
BUPA Finance PLC
18 June 2020
Bupa Finance PLC
LEI Code: ZIMCVQHUFZ8GVHENP290
Bupa Finance plc announces the pricing of its offering of GBP300
million Fixed Rate Notes due 2027 and GBP350 million Fixed Rate
Subordinated Notes due 2035
18 June 2020
Bupa (The British United Provident Association Limited), the
international health insurer and provider, today announces that it
has successfully launched and priced GBP300 million 1.750 per cent.
fixed rate notes due 2027 (the "Senior Notes") and GBP350 million
4.125 per cent. fixed rate subordinated notes due 2035 (the "Tier 2
Notes") to be issued by its subsidiary, Bupa Finance plc. The
Senior Notes are guaranteed by Bupa.
The Senior Notes are expected to be rated A3 and BBB+ by Moody's
and Fitch respectively. The Tier 2 Notes are expected to be rated
Baa1 (hyb) and BBB- by Moody's and Fitch respectively.
The Senior Notes were priced at a spread over gilts of 175 basis
points and have a maturity date of 14 June 2027 and the Tier 2
Notes were priced at a spread over gilts of 375 basis points and
have a maturity date of 14 June 2035. The transactions attracted
strong demand from investors, with a combined orderbook at the
final pricing of over GBP1.35bn and having peaked at over
GBP1.65bn.
Bupa's Chief Financial Officer, Joy Linton said: "These bonds
enable us to enhance Bupa's strong liquidity and capital positions
and extend our debt maturity profile. We are very pleased with the
continued demonstration of support from our fixed income investor
base . We remain focused on continuing to improve our offer to our
customers and growing sustainably over the long term i n line with
our Strategic Framework and Five-Year Vision. "
For further information, please contact:
Investors
Investor Relations: ir@bupa.com
Media
Rupert Gowrley (Corporate Affairs): rupert.gowrley@bupa.com
DISCLAIMER
This announcement is for information purposes only and does not
constitute an offer to sell or the solicitation of an offer to buy
the Senior Notes and the Tier 2 Notes (together "the Notes") or any
other security and shall not constitute an offer, solicitation or
sale in the United States or in any jurisdiction in which, or to
any persons to whom, such offering, solicitation or sale would be
unlawful.
The Notes will not be registered under the U.S. Securities Act
of 1933, as amended (the "Securities Act"), or any U.S. state
securities laws, and may not be offered or sold within the United
States or to, or for the account or benefit of, U.S. persons except
pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the Securities Act. Accordingly,
the Notes will be only offered and sold to non-U.S. persons in
offshore transactions outside the United States in accordance with
Regulation S under the Securities Act.
Stabilisation in respect of the Notes may be conducted in
accordance with FCA and International Capital Market Association
Rules.
About Bupa
Bupa's purpose is helping people live longer, healthier, happier
lives. With no shareholders, our customers are our focus. We
reinvest profits into providing more and better healthcare for the
benefit of current and future customers.
Health insurance accounts for the major part of our business
with 17.5m customers and contributes 73% of revenue. We operate
clinics, dental centres and hospitals in some markets, with 15.8m
customers. We care for around 22,000 residents in our aged care
businesses in the UK, Australia, New Zealand and Spain.
We directly employ around 83,000 people, principally in the UK,
Australia, Spain, Chile, Poland, New Zealand, Hong Kong, Turkey,
Brazil, the US, Middle East and Ireland. We also have associate
businesses in Saudi Arabia and India.
For more information, visit www.bupa.com .
END
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IODBUGDLRSBDGGI
(END) Dow Jones Newswires
June 18, 2020 11:51 ET (15:51 GMT)
Bupa Fin.bds (LSE:BUPF)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Bupa Fin.bds (LSE:BUPF)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025